Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday

Silence Therapeutics PLC (NASDAQ: SLN) shares surged 125.7% to $19.60 after the company announced its acquisition by Merck KGaA for $20 per ADS, valuing the enterprise at $1.1 billion and the equity at approximately $1.3 billion. Despite a mixed day for U.S. stocks, other companies like Disc Medicine Inc (NASDAQ: IRON) and Veradermics Inc (NYSE: MANE) also saw significant gains, with Disc Medicine rising 24.7% to $70.90 following positive trial results, and Veradermics increasing 5.7% to $115.00 due to successful clinical trial outcomes.